News Search Results
Mar 04, 2025, 20:23 ET Avecho и Sandoz заключили эксклюзивное соглашение о лицензировании и разработке с целью коммерциализации КБД для лечения бессонницы в Австралии
г. [3] The societal and economic burden of insomnia in adults: An international study (Социальное и экономическое бремя бессонницы у взрослых: международное исследование), RAND, 2023 г.
More news about: Avecho Biotechnology
Mar 04, 2025, 14:55 ET Trintech continue de renforcer sa position de leader sur le marché en enregistrant des ventes record
Hospitality Management, Allwyn Entertainment, Binance Asia Services Pte, Cracker Barrel Old Country Store, FrieslandCampina Cheese & Butter, HomeToGo, Insomnia Cookies, KBP Brands, Purdue Federal Credit Union et WK Kellogg Co, pour n'en citer que quelques-uns. L'accent mis par Trintech sur le développement
More news about: Trintech
Mar 04, 2025, 14:38 ET Trintech sigue fortaleciendo su liderazgo en el mercado y generando reservas de ventas récord
Hospitality Management, Allwyn Entertainment, Binance Asia Services Pte, Cracker Barrel Old Country Store, FrieslandCampina Cheese & Butter, HomeToGo, Insomnia Cookies, KBP Brands, Purdue Federal Credit Union y WK Kellogg Co, por nombrar algunos. El enfoque de Trintech en cultivar un ecosistema de
More news about: Trintech
Mar 04, 2025, 11:29 ET Avecho et Sandoz concluent un accord exclusif de licence et de développement pour commercialiser le CBD contre l'insomnie en Australie
2021. [3] The societal and economic burden of insomnia in adults: An international study, RAND, 2023.
More news about: Avecho Biotechnology
Mar 04, 2025, 10:00 ET Trintech Continues to Strengthen Market Leadership, Driving Record-Breaking Sales Bookings
Management, Allwyn Entertainment, Binance Asia Services Pte, Cracker Barrel Old Country Store, FrieslandCampina Cheese & Butter, HomeToGo, Insomnia Cookies, KBP Brands, Purdue Federal Credit Union and WK Kellogg Co, to name a few. Trintech's focus on cultivating a game-changing partner
More news about: Trintech
Mar 04, 2025, 10:00 ET Trintech Continues to Strengthen Market Leadership, Driving Record-Breaking Sales Bookings
Hospitality Management, Allwyn Entertainment, Binance Asia Services Pte, Cracker Barrel Old Country Store, FrieslandCampina Cheese & Butter, HomeToGo, Insomnia Cookies, KBP Brands, Purdue Federal Credit Union and WK Kellogg Co, to name a few. Trintech's focus on cultivating a game-changing partner
More news about: Trintech
Mar 03, 2025, 19:27 ET Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia
innovative insomnia treatments. Nearly 9.5 million Australians experience symptoms of insomnia with approximately 3.6 million of those considered chronic[3]. Sandoz's extensive reach and expertise in the Australian market will ensures our products are widely accessible to insomnia patients across
More news about: Avecho Biotechnology
Mar 03, 2025, 17:00 ET Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia
innovative insomnia treatments. Nearly 9.5 million Australians experience symptoms of insomnia with approximately 3.6 million of those considered chronic[3]. Sandoz's extensive reach and expertise in the Australian market will ensures our products are widely accessible to insomnia patients across
More news about: Avecho Biotechnology
Mar 03, 2025, 08:30 ET Protega Pharmaceuticals collaborates with Wellgistics Health to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™
are dose related and are opioid related adverse reactions. The most frequent of these included nausea, constipation, vomiting, headache, pruritus, insomnia, dizziness, asthenia, and somnolence. DRUG INTERACTIONS Concomitant use of ROXYBOND with a CYP3A4 and CYP2D6 inhibitor, such
More news about: Protega
Feb 24, 2025, 06:00 ET Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program
a global leader in noninvasive neurostimulation technology, is making significant strides in addressing chronic insomnia among U.S. veterans. The company's FDA-cleared, drug-free insomnia treatment device, Modius Sleep, is now available to veterans through the U.S. Department of Veterans Affairs (VA)
More news about: Neurovalens
Feb 20, 2025, 08:49 ET Star Sleep & Wellness of Dallas Moves to a New Office to Offer Start-to-Finish, Comprehensive Sleep Therapy
Foundation, about 33.2 percent of Texans regularly get insufficient sleep in a 24-hour period. This means that up to a third of Texans may face issues like insomnia, loud snoring, sleep apnea, and frequent urination every night. Without treatment, these sleep issues can lead to many health problems, including high
More news about: Star Sleep & Wellness
Feb 13, 2025, 16:01 ET Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
2026.HETLIOZ® (tasimelteon) Vanda has initiated clinical programs for HETLIOZ® in pediatric insomnia and delayed sleep phase disorder (DSPD) and these programs are ongoing.Vanda's MAA for HETLIOZ® and HETLIOZ LQ® for
More news about: Vanda Pharmaceuticals Inc.
Feb 13, 2025, 08:00 ET Lindus Health and CDISC Collaborate on Innovative AI Initiative to Standardize Clinical Trial Data for Accelerated Research
tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company has raised over $80M from investors including Peter Thiel, Balderton, Creandum,
More news about: Lindus Health
Feb 06, 2025, 10:50 ET Consumer Healthcare Market to grow by USD 189.8 Billion (2025-2029), Rising awareness of lifestyle diseases boosts growth, Report on how AI is driving market transformation - Technavio
healthcare expenditures. Consumers seek affordable OTC goods, preventative medicine, and convenient solutions for common ailments like allergies, insomnia, and gastrointestinal issues. The market is vast, with products ranging from analgesics and weight loss products to sports nutrition and herbal remedies.The
More news about: Technavio
Feb 06, 2025, 08:00 ET Lipocine Receives Updated Regulatory Guidance on LPCN 1154
Symptoms of PPD include hallmarks of major depression, including, but not limited to, sadness, depressed mood, loss of interest, change in appetite, insomnia, sleeping too much, fatigue, difficulty thinking/concentrating, excessive crying, fear of harming the baby/oneself, and/or thoughts of death or suicide.
More news about: Lipocine Inc.
Feb 04, 2025, 09:15 ET Odell Beckham Jr. and Arcutis Tackle Seborrheic Dermatitis in a "Clear Win for Your Skin"
headache (1.1%). The most common adverse reactions (≥1%) for ZORYVE cream 0.3% for plaque psoriasis include diarrhea (3.1%), headache (2.4%), insomnia (1.4%), nausea (1.2%), application site pain (1.0%), upper respiratory tract infection (1.0%), and urinary tract infection (1.0%). The most
More news about: Arcutis Biotherapeutics, Inc.
Feb 03, 2025, 09:00 ET HoneyNaps' AI-Powered Sleep Diagnostic Software Designated as 73rd and 74th Innovative Medical Device by South Korea's Ministry of Food and Drug Safety
Simultaneous approval of AI solutions for diagnosing sleep disorders and digital therapeutics for insomniaDomestic certification secured following U.S. FDA approvalThe only company to possess both AI algorithm development and hardware technology
More news about: HoneyNaps
Jan 30, 2025, 10:30 ET Sleep Software Market to Hit USD 1,569.2 Million by 2030 with 10.1% CAGR | MarketsandMarkets™
and wearable devices and smartphones offer real-time sleep tracking, tailored insights, and proven solutions like Cognitive Behavioral Therapy for Insomnia. These advancements position telehealth and mHealth as key enablers in expanding the adoption of sleep software, meeting the growing demand for convenient,
More news about: MarketsandMarkets
Jan 28, 2025, 09:00 ET Becoming In the Age of Overwhelm
Leaders describe Becoming as a fundamental state change. The results are both tangible and profound. They report overcoming stress-induced insomnia, significantly enhancing focus, energy and decision-making. Others find clarity and resilience navigating unexpected challenges like personal loss,
More news about: Becoming Co
Jan 23, 2025, 23:15 ET Premature Ejaculation Treatment Market to Grow by USD 1.53 Billion (2025-2029), Off-Label Drug Efficacy Boosts Revenue, Report with AI-Powered Insights - Technavio
resources are essential for individuals seeking treatment. However, side effects like nausea, dizziness, headache, diarrhea, somnolence, fatigue, and insomnia from pharmaceutical treatments can limit their use. Behavioral therapy and interventions like glans sensitivity desensitization and planning techniques
More news about: Technavio
Jan 22, 2025, 08:00 ET Anti-CRO Lindus Health Raises $55M in Series B Funding to Transform the Clinical Trial Landscape
Pharmanovia on a Phase IV trial for insomnia. "We're thrilled to partner with Lindus Health in their mission to improve the clinical research ecosystem," said Suranga Chandratillake, General
More news about: Lindus Health
Jan 21, 2025, 16:05 ET The Inner Circle acknowledges, Debra Salter, MD, ABOM as a Pinnacle Lifetime Member
guided weight loss, hormone and genetic testing, and comprehensive management of conditions such as cardiovascular disease, diabetes, thyroid issues, insomnia, and nutrition or food sensitivity. Her patient-centered approach emphasizes individualized treatment, allowing her to educate each patient about their
More news about: The Inner Circle
Jan 21, 2025, 08:00 ET SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression
• trouble sleeping (insomnia) • new or worse irritability
More news about: Johnson & Johnson
Jan 17, 2025, 08:30 ET Five Reasons the TurfMutt Foundation Encourages Communities to Invest in Green Space
mortality, heart rate, and violence. Visits to parks, community gardens, and other green spaces may lower city dwellers' use of medications for anxiety, insomnia, depression, high blood pressure, and asthma, according to the Finnish Institute for Health and Welfare. Mental well-being goes up when
More news about: TurfMutt Foundation
Jan 15, 2025, 08:46 ET Soaak Clinics Expand 2025 Offerings with Acceptance of Major Healthcare Insurance in Tulsa Clinic
OK, help people with a fresh start to the new year. For more than 15 years, customers have used these services for anxiety, depression, ADD, ADHD, insomnia, and much more. Accepting major Insurance Providers for some services beginning January 2025, including:
More news about: Soaak Technologies